Monte Rosa Therapeutics Inc

XNAS: GLUE

Await Turnaround

Download real time

4.41 -0.02 (-0.45%)

64.44% Fall from 52W High

860.7K XNAS Volume

XNAS 16 Apr, 2025 5:30 PM (EDT)

271.3

Market Cap

Below industry Median

0.4

Beta 1Year

Very Low volatility

Monte Rosa Therapeutics Inc - GLUE - stock price prediction, stock price target, analyst ratings from 9 analysts

Monte Rosa Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of -29.2%, and profit growth estimate of -77.4% for FY25, based on top 9 analyst calls.

Forecaster Screeners